Restoring vision by regenerating photoreceptors in a mouse model of a genetic eye disease.
Photoreceptor Regeneration in a Murine Model of Leber Congenital Amaurosis
This study is exploring new ways to help restore vision in children with Leber congenital amaurosis by using gene therapy and special cell treatments to regenerate the light-sensing cells in the eye, with the hope of improving their sight.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10898891 on NIH RePORTER |
What this research studies
This research investigates ways to regenerate photoreceptors in a mouse model of Leber congenital amaurosis, a severe inherited condition that leads to childhood blindness. The approach involves using gene therapy and cell-based therapies to restore visual function, particularly focusing on transplanting specific types of photoreceptor precursor cells. By analyzing the genetic makeup of these cells, the researchers aim to enhance the integration and effectiveness of the treatments in late-stage retinal degeneration. The ultimate goal is to activate the body's own repair mechanisms to improve vision in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with Leber congenital amaurosis or similar retinal degenerative conditions.
Not a fit: Patients with advanced retinal degeneration who have already lost significant photoreceptor function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision in children suffering from severe inherited retinal diseases.
How similar studies have performed: Previous research has shown promise in using cell-based therapies for retinal regeneration, but this specific approach is novel and untested in humans.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Uyhazi, Katherine E. — University of Pennsylvania
- Study coordinator: Uyhazi, Katherine E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.